Compare CLDX & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | STBA |
|---|---|---|
| Founded | N/A | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 2008 | N/A |
| Metric | CLDX | STBA |
|---|---|---|
| Price | $29.45 | $40.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $43.80 | $41.25 |
| AVG Volume (30 Days) | ★ 798.4K | 210.7K |
| Earning Date | 11-10-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 3.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.46 |
| Revenue | $2,599,000.00 | ★ $391,893,000.00 |
| Revenue This Year | N/A | $7.40 |
| Revenue Next Year | $19.70 | $4.94 |
| P/E Ratio | ★ N/A | $11.60 |
| Revenue Growth | N/A | ★ 1.21 |
| 52 Week Low | $14.40 | $30.84 |
| 52 Week High | $29.83 | $43.67 |
| Indicator | CLDX | STBA |
|---|---|---|
| Relative Strength Index (RSI) | 67.48 | 59.35 |
| Support Level | $25.69 | $38.27 |
| Resistance Level | $27.03 | $40.70 |
| Average True Range (ATR) | 1.32 | 1.01 |
| MACD | 0.48 | 0.08 |
| Stochastic Oscillator | 93.11 | 77.50 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.